Abstract: A tangential on-board injector (TOBI), comprising: a body defining an annular passageway to receive cooling air, the TOBI defining a plurality of discharge nozzles; a rotating component mounted for rotation relative to the body about an axis of rotation; a seal extending between the body and the rotating component; a plurality of vanes circumferentially distributed about the axis of rotation and located downstream of the plurality of discharge nozzles relative to a flow of the cooling air circulating toward the seal from the plurality of discharge nozzles and upstream of the seal; and flow passages defined between the plurality of vanes, a flow passage of the flow passages extending along a passage axis, the passage axis having a tangential component at an outlet of the flow passage that is different than a tangential component of an exit flow axis of a nozzle of the plurality of discharge nozzles.

Abstract: A tangential on-board injector (TOBI), comprising: a body defining an annular passageway to receive cooling air, the TOBI defining a plurality of discharge nozzles; a rotating component mounted for rotation relative to the body about an axis of rotation; a seal extending between the body and the rotating component; a plurality of vanes circumferentially distributed about the axis of rotation and located downstream of the plurality of discharge nozzles relative to a flow of the cooling air circulating toward the seal from the plurality of discharge nozzles and upstream of the seal; and flow passages defined between the plurality of vanes, a flow passage of the flow passages extending along a passage axis, the passage axis having a tangential component at an outlet of the flow passage that is different than a tangential component of an exit flow axis of a nozzle of the plurality of discharge nozzles.

Abstract: A tangential on-board injector (TOBI) having: a body defining an annular passageway, discharge nozzles; a rotating component configured to be mounted for rotation relative to the body about an axis of rotation; a seal extending between the body and the rotating component; and flow passages circumferentially distributed about the axis of rotation and in fluid communication with the nozzles and the seal, the flow passages located upstream of the seal relative to a flow of the cooling air circulating toward the seal from the plurality of discharge nozzles, each of the flow passages extending along a respective passage axis, the passage axis of at least one of the flow passages having a tangential component at an outlet of the at least one of the flow passages that is different than a tangential component of an exit flow axis of at least one of the plurality of discharge nozzles.

Abstract: Systems and methods for regulating oil flow to an engine are described herein. An oil pressure target for the engine is determined based on one or more engine operating parameters. Oil flow to the engine is controlled based on the oil pressure target. Closed-loop feedback of oil pressure of the engine is obtained from at least one sensor during the controlling of the oil flow to the engine. A pressure difference between the oil pressure target and the closed-loop feedback of the oil pressure of the engine is determined. The oil flow to the engine is adjusted based on the pressure difference.

Abstract: Systems and methods for regulating oil flow to an engine are described herein. An oil pressure target for the engine is determined based on one or more engine operating parameters. Oil flow to the engine is controlled based on the oil pressure target. Closed-loop feedback of oil pressure of the engine is obtained from at least one sensor during the controlling of the oil flow to the engine. A pressure difference between the oil pressure target and the closed-loop feedback of the oil pressure of the engine is determined. The oil flow to the engine is adjusted based on the pressure difference.

Abstract: A tangential on-board injector (TOBI) having: a body defining an annular passageway, discharge nozzles; a rotating component configured to be mounted for rotation relative to the body about an axis of rotation; a seal extending between the body and the rotating component; and flow passages circumferentially distributed about the axis of rotation and in fluid communication with the nozzles and the seal, the flow passages located upstream of the seal relative to a flow of the cooling air circulating toward the seal from the plurality of discharge nozzles, each of the flow passages extending along a respective passage axis, the passage axis of at least one of the flow passages having a tangential component at an outlet of the at least one of the flow passages that is different than a tangential component of an exit flow axis of at least one of the plurality of discharge nozzles.

Abstract: A system and method for preparing a shelled crustacean body part for meat extraction are provided. The method involves capturing an image of said body part, evaluating the thickness of the shell from the image, determining from the thickness evaluation at least one laser parameter for forming a line of weakness within the shell, the line of weakness being dimensioned to facilitate meat extraction, while preserving the sensory characteristics of the meat, and sweeping a laser beam on the body part in accordance with the laser parameter to form the line of weakness within the shell. The method and system provide the advantage of facilitating meat extraction without compromising the quality or commercial value of the meat all while increasing productivity and performance in comparison with completely manual extraction techniques.

Abstract: The present invention provides compounds of Formula I: wherein Y, AA, W, R3? R2, R4, R5, R6, R7, X1, X2, X3, X4 and X5 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug or esters or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.

Abstract: A system and method for preparing a shelled crustacean body part for meat extraction are provided. The method involves capturing an image of said body part, evaluating the thickness of the shell from the image, determining from the thickness evaluation at least one laser parameter for forming a line of weakness within the shell, the line of weakness being dimensioned to facilitate meat extraction, while preserving the sensory characteristics of the meat, and sweeping a laser beam on the body part in accordance with the laser parameter to form the line of weakness within the shell. The method and system provide the advantage of facilitating meat extraction without compromising the quality or commercial value of the meat all while increasing productivity and performance in comparison with completely manual extraction techniques.

Abstract: The present invention provides compounds of Formula I: wherein Y, AA, W, R3? R2, R4, R5, R6, R7, X1, X2, X3, X4 and X5 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug or esters or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.

Abstract: The present invention provides imidazothiadiazole compounds of Formula (I) wherein A, B, D, Rx, R1, R2, R3, X1, X2 and s are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments.

Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Abstract: The present invention provides thiazole compounds of Formula I wherein X, Y, Z, X1, X2, X3, X4, X5, R1, R2, R4, R5, R6, R7, and W, are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug, ester or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.

Abstract: The present invention provides imidazothiadiazole compounds of Formula (I); Wherein W, Y, R0, R2, R4, Ra, Rb, X1, X2, X3 and X4 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug ester or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.

Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Abstract: Augmented reality-based method, apparatus and system for assisting an operator to perform a task on a moving object according to at least one characteristic of the object, uses projection of light onto the object according to object tracking task instruction data as it moves through the working zone to provide a visual instruction for the operator about the task to perform on the object.

Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.